✦ LIBER ✦

Matrix factorizations and representations of quivers II: Type ADE case

✍ Scribed by Hiroshige Kajiura; Kyoji Saito; Atsushi Takahashi

Book ID: 108051517
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 354 KB
Volume: 211
Category: Article
ISSN: 0001-8708
DOI: 10.1016/j.aim.2006.08.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Homogeneous domains connected with facto

Homogeneous domains connected with factors of type II∞and representations of infinite-dimensional groups

✍ R. S. Ismagilov 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 229 KB

Effects of soluble factors and extracell

Effects of soluble factors and extracellular matrix on DNA synthesis and surfactant gene expression in primary cultures of rat alveolar type II cells

✍ K. Sugahara; Robert J. Mason; John M. Shannon 📂 Article 📅 1998 🏛 Springer-Verlag 🌐 English ⚖ 713 KB

Suppression of transforming growth facto

Suppression of transforming growth factor-beta isoforms, TGF-β receptor type II, and myofibroblast differentiation in cultured human corneal and limbal fibroblasts by amniotic membrane matrix

✍ Scheffer C.G. Tseng; De-Quan Li; Xiang Ma 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 326 KB 👁 1 views

Down-regulation of the transforming growth factor-beta (TGF-␤) signaling system is a strategy for preventing scarring during wound healing. Human corneal and limbal fibroblasts were cultured on the stromal matrix side of preserved human amniotic membrane. The levels of TGF-␤1, ␤2, and ␤3 and TGF-␤ t

Adenoviral delivery of dominant-negative

Adenoviral delivery of dominant-negative transforming growth factor β type II receptor up-regulates transcriptional repressor SKI-like oncogene, decreases matrix metalloproteinase 2 in hepatic stellate cell and prevents liver fibrosis in rats

✍ Ana Marquez-Aguirre; Ana Sandoval-Rodriguez; Jaime Gonzalez-Cuevas; Miriam Bueno 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 574 KB

## Abstract ## Background Dominant‐negative transforming growth factor β type II receptor (TβRIIΔcyt) is a protein that blocks transforming growth factor (TGF‐β) signaling. Because the consequences of blocking TGF‐β have not been completely elucidated in liver fibrosis, we analysed the effects of